PFM Health Sciences’s Sana Biotechnology SANA Stock Holding History

PFM Health Sciences’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-110,834	Closed	-$605K	–	85
2024 Q2	$605K	Sell	110,834 -564,166	-84%	-$4.5M	0.03%	77
2024 Q1	$6.75M	Sell	675,000 -1,208,337	-64%	-$9.05M	0.32%	62
2023 Q4	$7.68M	Buy	1,883,337 +639,198	+51%	+$2.35M	0.46%	49
2023 Q3	$4.81M	Buy	1,244,139 +1,230,173	+8,808%	+$6.61M	0.23%	65
2023 Q2	$83.2K	Hold	13,966	–	–	﹤0.01%	83
2023 Q1	$45.7K	Sell	13,966 -48,810	-78%	-$195K	﹤0.01%	78
2022 Q4	$248K	Sell	62,776 -628,688	-91%	-$3.07M	0.01%	86
2022 Q3	$4.15M	Sell	691,464 -261,269	-27%	-$1.89M	0.15%	78
2022 Q2	$6.13M	Buy	952,733 +597,461	+168%	+$3.81M	0.23%	71
2022 Q1	$2.94M	Buy	+355,272	New	+$2.87M	0.11%	67

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

PFM Health Sciences's SANA Position: Q3 2024 in Review

PFM Health Sciences sold out of Sana Biotechnology (SANA) in Q3 2024, closing a stake of 110,834 shares — an estimated $605K sold.

PFM Health Sciences first reported a position in SANA in Q1 2022 and held it in 10 quarters. The position peaked at $7.68M in Q4 2023. 155 funds tracked by Wall St. Rank hold SANA as of Q3 2024.

PFM Health Sciences reported no remaining Sana Biotechnology position as of Q3 2024 after selling out during the quarter.
PFM Health Sciences sold 110,834 Sana Biotechnology shares in Q3 2024, an estimated $605K.
PFM Health Sciences first reported a position in Sana Biotechnology in Q1 2022 and held it in 10 quarters.
PFM Health Sciences's Sana Biotechnology position peaked at $7.68M in Q4 2023.
155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2024.

Based on PFM Health Sciences's 13F filing for Q3 2024, filed 14 Nov 2024.